BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tong T, Guan Y, Xiong H, Wang L, Pang J. A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma. Front Oncol 2020;10:1541. [PMID: 33042799 DOI: 10.3389/fonc.2020.01541] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Stares M, Chauhan V, Moudgil-Joshi J, Kong QG, Malik J, Sundaramurthy A, Elliott T, Mains E, Leung S, Laird A, Symeonides SN. Initial active surveillance for patients with metastatic renal cell carcinoma: 10 years' experience at a regional cancer Centre. Cancer Med 2022. [PMID: 36207803 DOI: 10.1002/cam4.5330] [Reference Citation Analysis]
2 Meng C, Gan L, Li K, Yi F, Peng L, Li J, Li Y. Prognostic nutritional index before surgical treatment may serve as a prognostic biomarker for patients with upper tract urothelial carcinoma: A systematic review and meta-analysis. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.972034] [Reference Citation Analysis]
3 Yeh K, Wang C, Ling HH, Peng C, Chen Z, Hsia S. Pretreatment Glasgow Prognostic Score Correlated with Serum Histidine Level and Three-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma and Optimal Performance Status. Nutrients 2022;14:3475. [DOI: 10.3390/nu14173475] [Reference Citation Analysis]
4 Zhang Y, Chen S, Chen H, Li W. A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer. Cancer Med 2022. [PMID: 35702873 DOI: 10.1002/cam4.4940] [Reference Citation Analysis]
5 Voorn M, Beukers K, Trepels C, Bootsma G, Bongers B, Janssen-heijnen M. Associations between pretreatment nutritional assessments and treatment complications in patients with stage I-III non-small cell lung cancer: A systematic review. Clinical Nutrition ESPEN 2022;47:152-62. [DOI: 10.1016/j.clnesp.2021.12.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Xu S, Song L, Liu X. Prognostic Value of Pretreatment Glasgow Prognostic Score/Modified Glasgow Prognostic Score in Ovarian Cancer: A Systematic Review and Meta-Analysis. Nutr Cancer 2021;:1-8. [PMID: 34549675 DOI: 10.1080/01635581.2021.1980591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Nishikawa H, Goto M, Fukunishi S, Asai A, Nishiguchi S, Higuchi K. Cancer Cachexia: Its Mechanism and Clinical Significance. Int J Mol Sci 2021;22:8491. [PMID: 34445197 DOI: 10.3390/ijms22168491] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
8 Huang L, Han H, Zhou L, Chen X, Xu Q, Xie J, Zhan P, Chen S, Lv T, Song Y. Evaluation of the Lung Immune Prognostic Index in Non-Small Cell Lung Cancer Patients Treated With Systemic Therapy: A Retrospective Study and Meta-Analysis. Front Oncol 2021;11:670230. [PMID: 34249708 DOI: 10.3389/fonc.2021.670230] [Reference Citation Analysis]
9 He C, Zhao C, Zhang Y, Chen C, Lin X. An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection. J Inflamm Res 2021;14:1859-72. [PMID: 34012285 DOI: 10.2147/JIR.S311084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Marchioni M, Rivas JG, Autran A, Socarras M, Albisinni S, Ferro M, Schips L, Scarpa RM, Papalia R, Esperto F. Biomarkers for Renal Cell Carcinoma Recurrence: State of the Art. Curr Urol Rep 2021;22:31. [PMID: 33886004 DOI: 10.1007/s11934-021-01050-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]